CLINICAL TRIALS PROFILE FOR GLUMETINIB
✉ Email this page to a colleague
Clinical Trials for Glumetinib
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT03457532 ↗ | A Phase I Study of SCC244 | Recruiting | Haihe Biopharma Co., Ltd. | Phase 1 | This is a Phase 1a/1b multi-center and open label study to evaluate the safety, tolorability, pharmacokinetics and priliminary efficacy of SCC244 in advanced solid tumors patients with c-MET alteration |
| NCT03457532 ↗ | A Phase I Study of SCC244 | Recruiting | ShangHai HaiHe Pharmaceutical | Phase 1 | This is a Phase 1a/1b multi-center and open label study to evaluate the safety, tolorability, pharmacokinetics and priliminary efficacy of SCC244 in advanced solid tumors patients with c-MET alteration |
| NCT03466268 ↗ | Study to Evaluate the Safety and Anti-tumor Activity of SCC244 | Unknown status | Haihe Biopharma Co., Ltd. | Phase 1 | This study evaluates the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of SCC244 in patients with advanced solid tumors with c-Met Alterations. |
| NCT03466268 ↗ | Study to Evaluate the Safety and Anti-tumor Activity of SCC244 | Unknown status | ShangHai HaiHe Pharmaceutical | Phase 1 | This study evaluates the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of SCC244 in patients with advanced solid tumors with c-Met Alterations. |
| NCT04270591 ↗ | Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer | Recruiting | Haihe Biopharma Co., Ltd. | Phase 1/Phase 2 | Indication:Patients with Advanced c-MET-positive Non-Small Cell Lung Cancer Phase Ib (China only): Approximately 15 patients Phase Ⅱ (globally): Approximately 90 evaluable patients; addition of at least 6 patients in Safety Run-in (US only) |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Glumetinib
Condition Name
| Condition Name | |
| Intervention | Trials |
| Advanced Solid Tumor | 2 |
| C-Met Exon 14 Mutation | 1 |
| Healthy Volunteers | 1 |
| Locally Advanced/Recurrent or Distant Metastasized Non-small Cell Lung Cancer With MET Overexpression | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for Glumetinib
Trials by Country
Clinical Trial Progress for Glumetinib
Clinical Trial Phase
Clinical Trial Sponsors for Glumetinib
Sponsor Name
